MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.540
+0.050 (3.36%)
Sep 5, 2025, 4:00 PM - Market closed

MAIA Biotechnology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Selling, General & Admin
7.846.959.077.244.295.56
Upgrade
Research & Development
11.9410.0111.118.933.51.41
Upgrade
Operating Expenses
19.7816.9620.1816.187.796.98
Upgrade
Operating Income
-19.78-16.96-20.18-16.18-7.79-6.98
Upgrade
Interest Expense
-0-0-0.01-0.01-0.83-0.03
Upgrade
Interest & Investment Income
0.350.320.03000
Upgrade
Other Non Operating Income (Expenses)
3.26-6.620.380.41-1.71-0.01
Upgrade
EBT Excluding Unusual Items
-16.17-23.25-19.77-15.77-10.32-7.02
Upgrade
Gain (Loss) on Sale of Investments
----0.45--
Upgrade
Other Unusual Items
-----2.260.06
Upgrade
Pretax Income
-16.17-23.25-19.77-16.22-12.58-6.96
Upgrade
Earnings From Continuing Operations
-16.17-23.25-19.77-16.22-12.58-6.96
Upgrade
Minority Interest in Earnings
----0.070.32
Upgrade
Net Income
-16.17-23.25-19.77-16.22-12.5-6.64
Upgrade
Net Income to Common
-16.17-23.25-19.77-16.22-12.5-6.64
Upgrade
Shares Outstanding (Basic)
272213954
Upgrade
Shares Outstanding (Diluted)
272213954
Upgrade
Shares Change (YoY)
55.08%67.38%42.95%75.75%19.23%17.44%
Upgrade
EPS (Basic)
-0.60-1.05-1.49-1.75-2.37-1.50
Upgrade
EPS (Diluted)
-0.60-1.05-1.49-1.75-2.37-1.50
Upgrade
EBIT
-19.78-16.96-20.18-16.18-7.79-6.98
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q